ImmunologybioRxivPreprint
A nasal vaccine candidate, based on S2 and N proteins from SARS-CoV-2, generates a broad antibody response systemic and at lower respiratory tract.
Yadira Lobaina, Rong Chen, Dania Vázquez‐Blomquist…·Lisset Hermida
This paper evaluates a nasal SARS-CoV-2 vaccine candidate based on S2 and N proteins, showing broad antibody responses and mucosal immunity in mice.
DOI 10.1101/2025.05.09.653001